Abstract
The amyloid cascade hypothesis describes a series of cumulative events that are initiated by amyloid β-peptide and finally lead to synapse and neuron loss. Obviously, the proteases involved in amyloid β-peptide generation are targets for therapeutic treatment strategies. For the development of a safe therapeutic intervention, however, we must understand the precise physiological functions and the cellular mechanisms involved in substrate recognition, selection and cleavage. Moreover, homologous proteases, whose physiological function could be affected by inhibitors, need to be discovered and assays must be developed to help determine the cross-reactive potential of such inhibitors. Here we will focus on the intramembrane cleavage of the β-amyloid precursor protein, which is performed by the γ-secretase complex. In parallel, the cellular and biochemical properties of other proteases belonging to the same family of GxGD-type aspartyl proteases, the signal peptide peptidase and their homologues, will be described. We present a common, multiple intramembrane cleavage mechanism performed by these proteases and evidence that Alzheimer's disease-associated mutations lead to a partial loss of intramembrane proteolysis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Annaert W, De Strooper B (1999) Presenilins: molecular switches between proteolysis and signal transduction. Trends Neurosci 22: 439–443
Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, George-Hyslop PS, Cordell B, Fraser P, De Strooper B (1999) Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147: 277–294
Beher D, Clarke EE, Wrigley JD, Martin AC, Nadin A, Churcher I, Shearman MS (2004) Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism. J Biol Chem 279: 43419–43426
Ben-Shem A, Fass D, Bibi E (2007) Structural basis for intramembrane proteolysis by rhomboid serine proteases. Proc Natl Acad Sci USA 104: 462–466
Brown MS, Goldstein JL (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96: 11041–11048.
Capell A, Beher D, Prokop S, Steiner H, Kaether C, Shearman MS, Haass C (2005) Gamma-secretase complex assembly within the early secretory pathway. J Biol Chem 280: 6471–6478
Checler F (2001) The multiple paradoxes of presenilins. J Neurochem 76: 1621–1627
Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, Gu Y, Sanjo N, Glista M, Rogaeva E, Wakutani Y, Pardossi-Piquard R, Ruan X, Tandon A, Checler F, Marambaud P, Hansen K, Westaway D, St George-Hyslop P, Fraser P (2006) TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 440: 1208–1212
Churcher I, Beher D (2005) Gamma-secretase as a therapeutic target for the treatment of Alzheimer's disease. Curr Phamaceut Design 11: 3363–3382
Cupers P, Bentahir M, Craessaerts K, Orlans I, Vanderstichele H, Saftig P, De Strooper B, Annaert W (2001) The discrepancy between presenilin subcellular localization and γ-secretase processing of amyloid precursor protein. J Cell Biol 154: 731–740
Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C (2003) Reconstitution of γ-secretase activity. Nature Cell Biol 5: 486–488
Feng L, Yan H, Wu Z, Yan N, Wang Z, Jeffrey PD, Shi Y (2007) Structure of a site-2 protease family intramembrane metalloprotease. Science 318: 1608–1612
Fluhrer R, Grammer G, Israel L, Condron MM, Haffner C, Friedmann E, Bohland C, Imhof A, Martoglio B, Teplow DB, Haass C (2006) A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b. Nature Cell Biol 8: 894–896
Fluhrer R, Steiner H, Haass C (2008) Intramembrane Proteolysis by gamma-Secretase and related GxGD-type Aspartylproteases. J Biol Chem, in press
Fluhrer R, Fukumori A, Martin L, Grammer G, Haug-Kröper M, Klier B, Winkler E, Kremmer E, Condron MM, Teplow DB, Steiner H, Haass C (2008) Intramembrane proteolysis of G×GD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation. J Biol Chem, in press
Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, Nicoll M, Maxwell M, Hai B, Ellis MC, Parks AL, Xu W, Li J, Gurney M, Myers RL, Himes CS, Hiebsch RD, Ruble C, Nye JS, Curtis D (2002) aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation. Dev Cell 3: 85–97
Friedmann E, Lemberg MK, Weihofen A, Dev KK, Dengler U, Rovelli G, Martoglio B (2004) Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. JBbiol Chem 279: 50790–50798
Friedmann E, Hauben E, Maylandt K, Schleeger S, Vreugde S, Lichtenthaler SF, Kuhn PH, Stauffer D, Rovelli G, Martoglio B (2006) SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production. Nature Cell Biol 8: 843–848
Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Wooley K (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370: 555–557
Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC (2007) Structural basis for autoinhibition of Notch. Nature Struct Mol Biol 14: 295–300
Goutte C, Tsunozaki M, Hale VA, Priess JR (2002) APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci USA 99: 775–779.
Haass C (2004) Take five-BACE and the γ-secretase quartet conduct Alzheimer's amyloid β-peptide generation. EMBO J 23: 483–488
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nature Rev Mol Cell Biol 8: 101–112
Haass C, Steiner H (2002) Alzheimer disease γ-secretase: a complex story of GxGD-type presenilin proteases. Trends Cell Biol 12: 556–562
Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ (1993) beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021–3024
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353–356
Hasegawa H, Sanjo N, Chen F, Gu YJ, Shier C, Petit A, Kawarai T, Katayama T, Schmidt SD, Mathews PM, Schmitt-Ulms G, Fraser PE, St George-Hyslop P (2004) Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes. J Biol Chem 279: 46455–46463
Hooper NM, Karran EH, Turner AJ (1997) Membrane protein secretases. Biochem J 321 (Pt 2): 265–279
Iben LG, Olson RE, Balanda LA, Jayachandra S, Robertson BJ, Hay V, Corradi J, Prasad CV, Zaczek R, Albright CF, Toyn JH (2007) Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology. J Biol Chem 282: 36829–36836
Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A, Steiner H, Haass C (2002) Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. J Cell Biol 158: 551–561
Kaether C, Capell A, Edbauer D, Winkler E, Novak B, Steiner H, Haass C (2004) The presenilin C-terminus is required for ER-retention, nicastrin-binding and gamma-secretase activity. EMBO J 23: 4738–4748
Kaether C, Scheuermann J, Fassler M, Zilow S, Shirotani K, Valkova C, Novak B, Kacmar S, Steiner H, Haass C (2007) Endoplasmic reticulum retention of the gamma-secretase complex component Pen2 by Rer1. EMBO Rep 8: 743–748
Kirkin V, Cahuzac N, Guardiola-Serrano F, Huault S, Luckerath K, Friedmann E, Novac N, Wels WS, Martoglio B, Hueber AO, Zornig M (2007) The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Cell Death Differentiation 14: 1678–1687
Kopan R, Ilagan MX (2004) Gamma-secretase: proteasome of the membrane? Nature Rev Mol Cell Biol 5: 499–504
Kornilova AY, Bihel F, Das C, Wolfe MS (2005) The initial substrate-binding site of gamma-secretase is located on presenilin near the active site. Proc Natl Acad Sci USA102: 3230–3235
Krawitz P, Haffner C, Fluhrer R, Steiner H, Schmid B, Haass C (2005) Differential localization and identification of a critical aspartate suggest non-redundant proteolytic functions of the presenilin homologues SPPL2b and SPPL3. J Biol Chem 280: 39515–39523
Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45–53
LaPointe CF, Taylor RK (2000) The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases. J Biol Chem 275: 1502–1510
Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ, Li H (2006) From the Cover: Electron microscopic structure of purified, active {gamma}-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci USA 103: 6889–6894
Lemberg MK, Martoglio B (2002) Requirements for signal peptide peptidase-catalyzed intramem-brane proteolysis. Mol Cell 10: 735–744
Lemberg MK, Freeman M (2007) Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases. Genome Res 17: 1634–1646
Lemieux MJ, Fischer SJ, Cherney MM, Bateman KS, James MN (2007) The crystal structure of the rhomboid peptidase from Haemophilus influenzae provides insight into intramembrane proteolysis. Proc Natl Acad Sci USA104: 750–754
Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487–501
Martin L, Fluhrer R, Reiss K, Kremmer E, Saftig P, Haass C (2008) Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J Biol Chem 283: 1644–1652
McGeehan GM, Becherer JD, Bast RC, Jr., Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S, et al. (1994) Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370: 558–561
Miklossy J, Taddei K, Suva D, Verdile G, Fonte J, Fisher C, Gnjec A, Ghika J, Suard F, Mehta PD, McLean CA, Masters CL, Brooks WS, Martins RN (2003) Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease. Neurobiol Aging 24: 655–662
Munter LM, Voigt P, Harmeier A, Kaden D, Gottschalk KE, Weise C, Pipkorn R, Schaefer M, Langosch D, Multhaup G (2007) GxxxG motifs within the amyloid precursor protein trans-membrane sequence are critical for the etiology of Abeta42. EMBO J 26: 1702–1712
Nyborg AC, Jansen K, Ladd TB, Fauq A, Golde TE (2004a) A signal peptide peptidase (SPP) reporter activity assay based on the cleavage of type II membrane protein substrates provides further evidence for an inverted orientation of the SPP active site relative to presenilin. J Biol Chem 279: 43148–43156
Nyborg AC, Kornilova AY, Jansen K, Ladd TB, Wolfe MS, Golde TE (2004b) Signal peptide peptidase forms a homodimer that is labeled by an active site-directed gamma-secretase inhibitor. J Biol Chem 279: 15153–15160
Ponting CP, Hutton M, Nyborg A, Baker M, Jansen K, Golde TE (2002) Identification of a novel family of presenilin homologues. Human Mol Genet 11: 1037–1044
Prokop S, Shirotani K, Edbauer D, Haass C, Steiner H (2004) Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex. J Biol Chem 279: 23255–23261
Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, Horikoshi Y, Kametani F, Maeda M, Saido TC, Wang R, Ihara Y (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci 25: 436–445
Rawson RB, Zelenski NG, Nijhawan D, Ye J, Sakai J, Hasan MT, Chang TY, Brown MS, Goldstein JL (1997) Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell 1: 47–57.
Sato T, Nyborg AC, Iwata N, Diehl TS, Saido TC, Golde TE, Wolfe MS (2006) Signal peptide peptidase: biochemical properties and modulation by nonsteroidal antiinflammatory drugs. Biochemistry 45: 8649–8656
Sato T, Diehl TS, Narayanan S, Funamoto S, Ihara Y, De Strooper B, Steiner H, Haass C, Wolfe MS (2007) Active gamma-secretase complexes contain only one of each component. J Biol Chem 282: 33985–33993
Schlondorff J, Blobel CP (1999) Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Sell Sci 112 (Pt 21): 3603–3617
Selkoe D, Kopan R (2003) Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26: 565–597
Shah S, Lee SF, Tabuchi K, Hao YH, Yu C, LaPlant Q, Ball H, Dann CE, 3rd, Sudhof T, Yu G (2005) Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122: 435–447
Steiner H, Kostka M, Romig H, Basset G, Pesold B, Hardy J, Capell A, Meyn L, Grim MG, Baumeister R, Fechteler K, Haass C (2000) Glycine 384 is required for presenilin-1 function and is conserved in polytopic bacterial aspartyl proteases. Nature Cell Biol 2: 848–851
Steiner H, Than M, Bode W, Haass C (2006) Pore-forming scissors? A first structural glimpse of gamma-secretase. Trends Biochem Sci 31: 491–493
Takahashi Y, Hayashi I, Tominari Y, Rikimaru K, Morohashi Y, Kan T, Natsugari H, Fukuyama T, Tomita T, Iwatsubo T (2003) Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. J Biol Chem 278: 18664–18670
Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey AI, Gandy SE, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17: 181–190
Tsachaki M, Ghiso J, Rostagno A, Efthimiopoulos S (2008) BRI2 homodimerizes with the involvement of intermolecular disulfide bonds. Neurobiol Aging, in press
Vassalli P (1992) The pathophysiology of tumor necrosis factors. Ann Rev Immunol 10: 411–452
Vetrivel KS, Zhang X, Meckler X, Cheng H, Lee S, Gong P, Lopes KO, Chen Y, Iwata N, Yin KJ, Lee JM, Parent AT, Saido TC, Li YM, Sisodia SS, Thinakaran G (2008) Evidence that CD147 modulation of Abeta levels is mediated by extracellular degradation of secreted Abeta. J Biol Chem, in press
Wang J, Beher D, Nyborg AC, Shearman MS, Golde TE, Goate A (2006a) C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation. J Neurochem 96: 218–227
Wang Y, Zhang Y, Ha Y (2006b) Crystal structure of a rhomboid family intramembrane protease. Nature 444: 179–180
Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414: 212–216
Weihofen A, Martoglio B (2003) Intramembrane-cleaving proteases: controlled liberation of functional proteins and peptides from membranes. Trends Cell Biol 13: 71–78
Weihofen A, Binns K, Lemberg MK, Ashman K, Martoglio B (2002) Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296: 2215–2218
Weihofen A, Lemberg MK, Friedmann E, Rueeger H, Schmitz A, Paganetti P, Rovelli G, Martoglio B (2003) Targeting presenilin-type aspartic protease signal peptide peptidase with gamma-secretase inhibitors. J Biol Chem 278: 16528–16533
Wolfe MS, Kopan R (2004) Intramembrane proteolysis: theme and variations. Science 305: 1119–1123
Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398: 513–517
Wu Z, Yan N, Feng L, Oberstein A, Yan H, Baker RP, Gu L, Jeffrey PD, Urban S, Shi Y (2006) Structural analysis of a rhomboid family intramembrane protease reveals a gating mechanism for substrate entry. Nature Struct Mol Biol 13: 1084–1091
Yamasaki A, Eimer S, Okochi M, Smialowska A, Kaether C, Baumeister R, Haass C, Steiner H (2006) The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase. J Neurosci 26: 3821–3828
Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, Brown MS, Goldstein JL (2000) ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 6: 1355–1364.
Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, Supala A, Levesque L, Yu H, Yang DS, Holmes E, Milman P, Liang Y, Zhang DM, Xu DH, Sato C, Rogaev E, Smith M, Janus C, Zhang Y, Aebersold R, Farrer LS, Sorbi S, Bruni A, Fraser P, St George-Hyslop P (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature 407: 48–54.
Zhou S, Zhou H, Walian PJ, Jap BK (2005) CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Proc Natl Acad Sci USA102: 7499–7504
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fluhrer, R., Haass, C. (2009). Intramembrane Proteolysis by γ-Secretase and Signal Peptide Peptidases. In: George-Hyslop, P.H.S., Mobley, W.C., Christen, Y. (eds) Intracellular Traffic and Neurodegenerative Disorders. Research and Perspectives in Alzheimer's Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-87941-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-540-87941-1_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-87940-4
Online ISBN: 978-3-540-87941-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)